ProCE Banner Activity

Incorporating New Prevention and Treatment Strategies Into HIV Care

Slideset Download
Case Challenge
Review the latest data on FTC/TAF as PrEP and extended-release injectable CAB plus RPV for long-acting treatment of patients with HIV.

Released: January 28, 2020

Expiration: January 26, 2021

No longer available for credit.

Share

Faculty

Anne-Geneviève Marcelin

Anne-Geneviève Marcelin, PharmD, PhD

Professor of Medicine, Inserm U1136
Sorbonne Université
Professor of Medicine, Virologie
APHP Hôpital Pitié-Salpêtrière
Paris, France

Kenneth Mayer

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Jürgen K. Rockstroh

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany  

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare

Faculty Disclosure

Primary Author

Anne-Geneviève Marcelin, PharmD, PhD

Professor of Medicine, Inserm U1136
Sorbonne Université
Professor of Medicine, Virologie
APHP Hôpital Pitié-Salpêtrière
Paris, France

Kenneth Mayer, MD

Infectious Disease Attending
Beth Israel Deaconess Medical Center
Professor of Medicine
Harvard Medical School
Medical Research Director
Fenway Community Health
Boston, Massachusetts

Jürgen K. Rockstroh, MD

Head of Infectious Diseases
Professor of Medicine 
University Hospital Bonn
Bonn, Germany